1 hr ago
Abhayrab Potency Test Raises Questions Over Seized Vaccine Vials
A rabies vaccine sample that was seized reportedly did not pass a strength test.
The company that makes Abhayrab says the seized vials were not made by it.
This means investigators still need to determine whether the sample was genuine.
The findings do not prove that every Abhayrab vaccine is unsafe.
They also do not prove that the real KE25012 batch failed its quality tests.
People who received a rabies vaccine after an animal bite should not stop their treatment on their own.
Anyone worried about a vial or batch number should contact a doctor or health authority.
Getting advice quickly is important after possible rabies exposure.
A seized Abhayrab vaccine sample reportedly failed a potency test.
The findings do not establish that all Abhayrab vaccines are unsafe.
They also do not show that genuine KE25012-batch vaccines made by Indian Immunologicals Limited failed testing.
Indian Immunologicals Limited says the seized vials were not manufactured by the company.
People receiving rabies vaccination after possible exposure should not change their schedule solely because of the investigation.
- Who
- Indian Immunologicals Limited, investigators, and people vaccinated after possible rabies exposure.
- What
- A seized Abhayrab vaccine sample reportedly failed a potency test, while the manufacturer disputes that the vials were genuine company products.
- Where
- Not specified in the provided information.
- When
- The latest findings; no specific date is provided.
- Why
- The investigation is examining the potency of the seized sample and whether the vials were genuinely manufactured by Indian Immunologicals Limited.
Investigation Findings
Manufacturer's Position
Potency of seized vials
Investigation Findings
The seized Abhayrab sample reportedly failed a potency test, raising concerns about the specific vials examined.
Manufacturer's Position
Indian Immunologicals Limited says the seized vials were not manufactured by the company, so their test result may not reflect genuine Abhayrab products.
Safety of the wider vaccine supply
Investigation Findings
The failed sample has prompted an investigation into whether the seized product was authentic and suitable for use.
Manufacturer's Position
The findings do not show that all Abhayrab vaccines are unsafe or that the genuine KE25012 batch failed quality testing.
Key facts
- Product
- Abhayrab rabies vaccine
- Test result
- The seized sample reportedly failed a potency test.
- Manufacturer's position
- Indian Immunologicals Limited says the seized vials were not made by the company.
- Batch referenced
- KE25012
- Scope of findings
- The findings do not establish that all Abhayrab vaccines are unsafe.
- Vaccination advice
- People should not stop or alter their vaccination schedule solely because of the investigation.
- Recommended action
- Questions about authenticity, batch numbers, or vaccination status should be directed promptly to a doctor or local health authority.
Sources
Related news
India Probes Abhayrab Batch After Potency Test Failure
Delhi Seizes Misbranded Abhayrab Vaccine; No Exports Confirmed
ICMR Rules Out New H1N1 Strain Amid India Circulation
Rare Reported Rabies Recovery Raises Questions About Survival
Teen Survives Late-Stage Rabies After Intensive Treatment
Tiger Sighting Triggers Panic, Forest Officials Seek Scientific Confirmation
India Rejects Chinese Polio Strain in 6-in-1 Vaccine
Australia Warns on Fake Rabies Vaccine
